Genzyme Corporation / Genzyme Biosurgery recalls Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured…

Recall date

August 4, 2016

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1518-2016

FDA classification

Class III

Brand / firm

Genzyme Corporation / Genzyme Biosurgery

Sold / distributed

nationwide

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp. Date

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01